Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial

NCT07919600 is registered in ClinicalTrials.gov with Hatice Zehra FERHATLAR as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07919600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial
Lead sponsor
Hatice Zehra FERHATLAR
Phase
Not applicable
Overall status
Recruiting
Start date
August 28, 2026
Completion date
January 29, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcaneal spur

Arms

As registered; 2 arms.

  • Active PEMF Group ExperimentalActive Pulsed Electromagnetic Field Therapy (PEMF)

    Participants in this group will receive active pulsed electromagnetic field (PEMF) therapy using a BTL-4000 magnetotherapy device with a solenoid applicator. Treatment will be administered at a magnetic field intensity of 2 mT and a frequency of 50 Hz for 20 minutes per session, three times per week for four weeks (12 sessions in total). All participants will also receive a standardized plantar fascia and gastrocnemius-soleus stretching exercise program.

  • Sham PEMF Group Sham comparatorSham Pulsed Electromagnetic Field Therapy (Sham PEMF)

    Participants in this group will undergo sham PEMF treatment using the same BTL-4000 magnetotherapy device, solenoid applicator, patient positioning, and session duration as the active treatment group. However, the electromagnetic field output will remain deactivated throughout each session. Sham treatment will be administered for 20 minutes per session, three times per week for four weeks (12 sessions in total). All participants will also receive the same standardized plantar fascia and gastrocnemius-soleus stretching exercise program.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in Morning First-Step Pain Intensity Assessed by Visual Analog Scale (VAS) Baseline (Week 0), Week 4, Week 8, and Week 12

    Morning first-step heel pain intensity will be assessed using a Visual Analog Scale (VAS), with higher scores indicating greater pain intensity. The change from baseline will be compared between the active PEMF and sham PEMF groups at weeks 4, 8, and 12.

Lead sponsor's other trials

Hatice Zehra FERHATLAR, most recent start first.

Similar trials

Same condition (Heel Spur) and phase, most recent start first.